But abstinence can be a higher bar comparable to requiring that an antidepressant create full remission of despair or that an analgesic fully do away with agony. Recognizing this limitation, the FDA encourages developers of opioid2 and stimulant3 use condition medicines to discuss with FDA choice methods to measure improvements https://g.page/r/Cdpi1-Ui8ZAiEBM